CD82 and non-small cell lung carcinoma: Previous studies have linked TSPAN27 and TM4SF1 with the occurrence of PTC(Haddad et al., 2018), and TM4SF1 was reported to be a useful biomarker in the diagnosis and treatment of non-small cell lung cancer (Ma et al., 2018).